JP6563685B2 - オピオイドと組み合わせたパルミトイルエタノールアミドの使用 - Google Patents

オピオイドと組み合わせたパルミトイルエタノールアミドの使用 Download PDF

Info

Publication number
JP6563685B2
JP6563685B2 JP2015098334A JP2015098334A JP6563685B2 JP 6563685 B2 JP6563685 B2 JP 6563685B2 JP 2015098334 A JP2015098334 A JP 2015098334A JP 2015098334 A JP2015098334 A JP 2015098334A JP 6563685 B2 JP6563685 B2 JP 6563685B2
Authority
JP
Japan
Prior art keywords
opioid
treatment
palmitoylethanolamide
micronized
pea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015098334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015221794A5 (enExample
JP2015221794A (ja
Inventor
フランチェスコ・デッラ・ヴァッレ
マリア・フェデリカ・デッラ・ヴァッレ
ロレンツォ・ディ・チェーザレ・マネッリ
カルラ・ゲラルディーニ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epitech Group SpA
Original Assignee
Epitech Group SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitech Group SpA filed Critical Epitech Group SpA
Publication of JP2015221794A publication Critical patent/JP2015221794A/ja
Publication of JP2015221794A5 publication Critical patent/JP2015221794A5/ja
Application granted granted Critical
Publication of JP6563685B2 publication Critical patent/JP6563685B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dispersion Chemistry (AREA)
JP2015098334A 2014-05-14 2015-05-13 オピオイドと組み合わせたパルミトイルエタノールアミドの使用 Active JP6563685B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20140876 2014-05-14
ITMI2014A000876 2014-05-14

Publications (3)

Publication Number Publication Date
JP2015221794A JP2015221794A (ja) 2015-12-10
JP2015221794A5 JP2015221794A5 (enExample) 2018-06-14
JP6563685B2 true JP6563685B2 (ja) 2019-08-21

Family

ID=51179022

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015098334A Active JP6563685B2 (ja) 2014-05-14 2015-05-13 オピオイドと組み合わせたパルミトイルエタノールアミドの使用

Country Status (17)

Country Link
US (1) US9801836B2 (enExample)
EP (1) EP2944309B1 (enExample)
JP (1) JP6563685B2 (enExample)
KR (1) KR102507891B1 (enExample)
CN (1) CN105079811B (enExample)
AR (1) AR100444A1 (enExample)
AU (1) AU2015202575B9 (enExample)
BR (1) BR102015011079A2 (enExample)
CA (1) CA2891049C (enExample)
CY (1) CY1121773T1 (enExample)
DK (1) DK2944309T3 (enExample)
ES (1) ES2731729T3 (enExample)
HU (1) HUE044915T2 (enExample)
PL (1) PL2944309T3 (enExample)
PT (1) PT2944309T (enExample)
SM (1) SMT201900345T1 (enExample)
TR (1) TR201908936T4 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL322263A (en) * 2015-05-21 2025-09-01 Scisparc Ltd Combinations of opioids and acetylamines
PH12018000077B1 (en) 2017-07-05 2021-07-09 Frimline Private Ltd A pharmaceutical composition for neuropathic pain
PH12018000227A1 (en) 2017-09-05 2019-03-11 Frimline Private Ltd A pharmaceutical composition for improving or preventing progression of chronic kidney disease
WO2020141546A1 (en) * 2019-01-02 2020-07-09 Celagenex Research (India) Pvt. Ltd. Synergistic nutritional compositions for pain management

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271266B (it) 1994-12-14 1997-05-27 Valle Francesco Della Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
US6548550B1 (en) 1999-08-06 2003-04-15 Innovet Italia S.R.L. Pharmaceutical compositions containing N-palmitoylethanolamide and use thereof in the veterinary field
ES2312643T5 (es) * 2001-07-18 2011-10-18 Unilever N.V. Composiciones para el tratamiento del cabello y/o del cuero cabelludo.
US20050245557A1 (en) * 2003-10-15 2005-11-03 Pain Therapeutics, Inc. Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain
JP2012522004A (ja) * 2009-03-27 2012-09-20 アボット・ラボラトリーズ カンナビノイド受容体リガンドである化合物
PL2796129T3 (pl) * 2009-09-07 2015-11-30 Epitech Group S P A Kompozycja zawierająca palmitoiloetanoloamid poddany ultramikronizacji

Also Published As

Publication number Publication date
KR102507891B1 (ko) 2023-03-08
AR100444A1 (es) 2016-10-05
KR20150130931A (ko) 2015-11-24
CA2891049C (en) 2023-02-21
CA2891049A1 (en) 2015-11-14
DK2944309T3 (da) 2019-06-03
BR102015011079A2 (pt) 2016-03-29
PL2944309T3 (pl) 2019-09-30
CN105079811B (zh) 2020-06-23
CN105079811A (zh) 2015-11-25
PT2944309T (pt) 2019-06-05
AU2015202575A1 (en) 2015-12-03
AU2015202575B9 (en) 2020-03-26
US20150328173A1 (en) 2015-11-19
HUE044915T2 (hu) 2019-11-28
SMT201900345T1 (it) 2019-07-11
US9801836B2 (en) 2017-10-31
TR201908936T4 (tr) 2019-07-22
AU2015202575B2 (en) 2020-03-05
CY1121773T1 (el) 2020-07-31
ES2731729T3 (es) 2019-11-18
EP2944309A1 (en) 2015-11-18
JP2015221794A (ja) 2015-12-10
EP2944309B1 (en) 2019-03-20

Similar Documents

Publication Publication Date Title
CA2782529C (en) Morphinan derivatives for the treatment of drug overdose
WO2007005716A2 (en) Methods of treatment and compositions for use thereof
JP6563685B2 (ja) オピオイドと組み合わせたパルミトイルエタノールアミドの使用
AU2021204517B2 (en) Combination of opioids and n-acylethanolamines
JP2014515405A (ja) オピオイド受容体アゴニストの逐次投与のための組成物
EP0514023A1 (en) Use of glycine/NMDA receptor ligands for the manufacture of a medicament for the treatment of drug dependence and withdrawal
JP2014505113A (ja) 末梢作用性μオピオイドアンタゴニスト
JP2015221794A5 (enExample)
WO2009007110A2 (en) Combination of benzyl-4,5-dihydro-1h-imidazole derivative and an opiod recptor ligand
HUP0301973A2 (hu) Opioid hatású vegyületet és (I) általános képletű vegyületet tartalmazó hatóanyag-kombináció és ezt tartalmazó gyógyszerkészítmények
NL2009514C2 (en) Pharmaceutical composition comprising methadone hydrochloride.
HK1223246A1 (zh) 疼痛药物组合及其用途
JPWO1997006139A1 (ja) 麻薬性鎮痛剤の依存・耐性形成抑制剤
HK1217408B (en) Pain medicine combination and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180424

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190425

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190610

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190625

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190725

R150 Certificate of patent or registration of utility model

Ref document number: 6563685

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250